TCL Archive Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials March 26, 1993
TCL Archive In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief April 5, 1974
TCL Archive Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials March 14, 1980